+971 56 274 1787WhatsApp
Symptom

Health Information

Comprehensive undefined information and treatment options at Healers Clinic Dubai.

"You are not alone in this journey."

15,000+ Patients
DHA Licensed
95% Success Rate
27+ Years
Expert Definition

Understanding This Symptom

Medical Definition

Subject Matter Expert Verified

Metabolic Syndrome (MetS) is a cluster of interconnected metabolic disorders that significantly increase cardiovascular disease and type 2 diabetes risk.

It is diagnosed when three or more of the following criteria are present: abdominal obesity (waist circumference >102 cm in men, >88 cm in women), elevated triglycerides (>=150 mg/dL), reduced HDL cholesterol (<40 mg/dL in men, <50 mg/dL in women), elevated blood pressure (>=130/85 mmHg), and elevated fasting glucose (>=100 mg/dL).

The syndrome represents a state of chronic metabolic dysfunction driven primarily by insulin resistance and visceral adiposity.

Quick Facts

Expert-reviewed by medical professionals
Based on current medical research
Updated for 2026 standards

Need More Information?

Our experts can provide personalized guidance

Book Consultation
Healthy State

What Optimal Health Looks Like

Understanding how your body functions when healthy helps identify dysfunction

In optimal metabolic health, the body maintains precise energy homeostasis through coordinated hormonal signaling.

Insulin efficiently facilitates glucose uptake into skeletal muscle and adipose tissue via GLUT4 translocation, while suppressing hepatic gluconeogenesis.

Adipose tissue functions as an endocrine organ, secreting balanced levels of adiponectin (insulin-sensitizing), leptin (satiety signaling), and inflammatory cytokines.

The liver maintains lipid homeostasis through regulated VLDL secretion and beta-oxidation.

Healthy Function

Your body is designed to maintain balance and self-regulate

Optimal Range
Development Process

How This Develops

1

Visceral Adiposity - expansion of intra-abdominal adipose tissue releases excess free fatty acids (FFAs) into the portal circulation, causing hepatic steatosis and insulin resistance; (

2

Insulin Resistance - ectopic lipid deposition in skeletal muscle and liver impairs insulin receptor substrate-

3

phosphorylation and PI

4

Adipokine Dysregulation - decreased adiponectin and increased leptin resistance further impair insulin sensitivity while promoting inflammation; (

5

Chronic Low-Grade Inflammation - adipose tissue macrophages (ATM) shift from M

6

Endothelial Dysfunction - reduced nitric oxide bioavailability and increased endothelin-

7

Dyslipidemia - hepatic overproduction of VLDL and impaired lipoprotein lipase activity create atherogenic lipid profiles; (

8

Oxidative Stress - mitochondrial dysfunction generates reactive oxygen species (ROS) that damage cellular components and activate pro-inflammatory pathways

Understanding the mechanism helps us target the root cause rather than just treating symptoms.

Cost of Waiting

What Happens If Left Untreated

Understanding the consequences helps you make informed decisions about your health

Short-Term Consequences

Days to weeks

  • [object Object] | [object Object] | [object Object]

Time Matters

Don't wait for symptoms to worsen. Early intervention leads to better outcomes.

Common Questions

Frequently Asked Questions

Expertise Behind This Guide

Evidence-Based Information

Dr. Hafeel Afsar, DHA Licensed Integrative Medicine Specialist with expertise in metabolic disorders, functional endocrinology, and root-cause resolution of chronic disease

References & Further Reading

Alberti KG et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 2009;120(16):1640-1645. PMID: 19805654
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12. PMID: 29480368
O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12. PMID: 25407540
Lorenzo C et al. Trends in Metabolic Syndrome Prevalence by Gender and Race/Ethnicity: The Dallas Heart Study. Diabetes Care. 2020;43(12):3121-3124. PMID: 33020064
Galassi A et al. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812-819. PMID: 17000207
Mottillo S et al. The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2010;56(14):1113-1132. PMID: 20863957
Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351-375. PMID: 15158523
Lakka HM et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716. PMID: 12460094
Cornier MA et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777-822. PMID: 18971485
Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887. PMID: 17167477

This information is for educational purposes and not a substitute for professional medical advice.